alendronate has been researched along with Autoimmune Diabetes in 3 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Excerpt | Relevance | Reference |
---|---|---|
"Alendronate was also able to reduce marrow adiposity in both control diabetic mice compared to untreated mice." | 1.42 | Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation. ( Baumann, MJ; Coe, LM; McCabe, LR; Shu, Y; Tekalur, SA, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Mostafavinia, A | 1 |
Ahadi, R | 1 |
Abdollahifar, M | 1 |
Ghorishi, SK | 1 |
Jalalifirouzkouhi, A | 1 |
Bayat, M | 1 |
Coe, LM | 1 |
Tekalur, SA | 1 |
Shu, Y | 1 |
Baumann, MJ | 1 |
McCabe, LR | 1 |
Vestergaard, P | 1 |
3 other studies available for alendronate and Autoimmune Diabetes
Article | Year |
---|---|
Evaluation of the Effects of Photobiomodulation on Biomechanical Properties and Hounsfield Unit of Partial Osteotomy Healing in an Experimental Rat Model of Type I Diabetes and Osteoporosis.
Topics: Alendronate; Animals; Biomechanical Phenomena; Blood Glucose; Diabetes Mellitus, Type 1; Disease Mod | 2017 |
Bisphosphonate treatment of type I diabetic mice prevents early bone loss but accentuates suppression of bone formation.
Topics: Alendronate; Animals; Bone Density; Bone Density Conservation Agents; Bone Resorption; Diabetes Mell | 2015 |
Risk of newly diagnosed type 2 diabetes is reduced in users of alendronate.
Topics: Age of Onset; Aged; Aged, 80 and over; Alendronate; Bone Density Conservation Agents; Case-Control S | 2011 |